Benzinga | Nov 3, 2020 04:07PM EST

Corcept Therapeutics Q3 EPS $0.24 Beats $0.20 Estimate, Sales $86.30M Miss $90.87M Estimate

Corcept Therapeutics (NASDAQ:CORT) reported quarterly earnings of $0.24 per share which beat the analyst consensus estimate of $0.20 by 20 percent. This is a 22.58 percent decrease over earnings of $0.31 per share from the same period last year. The company reported quarterly sales of $86.30 million which missed the analyst consensus estimate of $90.87 million by 5.03 percent. This is a 5.88 percent increase over sales of $81.50 million the same period last year.